Clin2
NCT07797322Possibly a fitNot yet recruiting

Study of PKN605 in people with kidney problems

Participants With Moderate and Severe Renal Impairment and Healthy Participants

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests how the body handles an investigational drug called PKN605 in people with different levels of kidney function. It aims to see if the drug is safe and how it is processed when kidneys are impaired, which can help doctors decide the right dose for people with kidney disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 80 years old and weigh at least 110 pounds with a body mass index between 18 and 42.
  • You have moderate or severe kidney disease (but you are not on dialysis), or you are a healthy person with normal kidney function.
  • You have not had a kidney transplant or a nephrectomy (surgery to remove a kidney).
  • You do not have a history of serious heart rhythm problems, long QT syndrome, or a family history of sudden cardiac death.
  • If you are on medications for blood pressure or diabetes, your dose must have been stable for at least 4 weeks before the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07808788Not yet recruiting· Phase 1
How a single dose of a study medicine moves through the body in people with different kidney function

This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.

Berlin
NCT07694544Recruiting· Phase 1
Oral EC5026 study in people with kidney disease

This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.

Sacramento, California
NCT07315360Recruiting· Phase 1
How a new medicine works in people with reduced kidney function

This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.

Lake Forest, California
NCT07854249Not yet recruiting· Phase 1
Study of INCB161734 in people with kidney problems

This study tests an experimental drug called INCB161734 in people with severe kidney disease or those on dialysis. It aims to see how the drug behaves in the body and if it is safe.

NCT07368712Recruiting
Study of kidney function in healthy people and those with kidney issues

This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.

Berlin
NCT07741604Recruiting· Phase 1
Kidney function safety study for RO7795081

This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.

Miami Lakes, Florida

Hear when a new Participants With Moderate and Severe Renal Impairment and Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.